MedTrace Logo

Familial Hypercholesterolemia Amongst Patients With Acute Coronary Syndrome

NCT02870660 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-11-30

No results posted yet for this study

Summary

Familial hypercholesterolemia (FH) is a most prevalent genetic disorder, defines as high cholesterol level and premature death. The prevalence of FH has been reported in few countries however unknown in Iran. Thus recognize the FH patients, determine the diagnostic strategies and appropriate treatments are important.

Also acute coronary syndrome (ACS) is a group of conditions which arises from reduction of blood flow in coronary arteries. Three specific conditions are included: ST elevation myocardial infarction, non ST elevation myocardial infarction and unstable angina. Premature ACS defined by occurrence of ACS\<55 for men and ACS\<60 for women. Studies demonstrated direct connection between familial hypercholesterolemia and occurrence of premature ACS. Investigators intent to detection of FH amongst patients with acute coronary syndrome.

Conditions

  • Familial Hypercholesterolemia
  • Cardiac Event
  • Acute Coronary Syndrome

Interventions

OTHER

Registry

Sponsors & Collaborators

  • Isfahan University of Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-09-30
Completion
2021-09-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02870660 on ClinicalTrials.gov